| |
siRNA Id: | aspsirna3171
|
siRNA Name: | miCAG9
|
Gene: | Hungtintin (HTT) |
Disease: | Huntington disease (HD) |
Wild allele/target (5'->3'): | CAACGACGACGACGACGACGAC
|
Mutant allele/target (5'->3'): | CAACGACGUCGACGACGACGAC
|
Target Mutation: | (CAG)81
|
Wild siRNA (As strand): | GUUGCUGCUGCUGCUGCUGCUG
|
ASP-siRNA (As strand): | GUUGCUGCAGCUGCUGCUGCUG
|
Mismatch position in siRNA: | A9U |
Mutant allele (5'->3'): | CAACGACGUCGACGACGACGAC
|
ASP-siRNA (As strand): | GUUGCUGCAGCUGCUGCUGCUG
|
ASP-siRNA efficacy for mutant allele: | 77
|
Wild allele (5'->3'): | CAACGACGACGACGACGACGAC
|
ASP-siRNA (As strand): | GUUGCUGCAGCUGCUGCUGCUG
|
ASP-siRNA efficacy for wild allele: | 50
|
Percentage discrimination for ASP-siRNA: | 27
|
Wild allele (5'->3'): | CAACGACGACGACGACGACGAC
|
Wild siRNA (As strand): | GUUGCUGCUGCUGCUGCUGCUG
|
Wild sirna efficacy for wild allele: | 45
|
Wild allele (5'->3'): | CAACGACGACGACGACGACGAC
|
ASP-siRNA (As strand): | GUUGCUGCAGCUGCUGCUGCUG
|
Wild sirna efficacy for mutant allele: | 57
|
Percentage discrimination for wild siRNA: | -12
|
Concentration: | 40 nM |
Orientation: | Double strand |
Mismatch in: | siRNA |
UniProt ID: | P42858 |
Target sequence: | NA |
Genbank Accesion: | NM_002111.7 |
Cell-line: | HEK-293 |
Experimental technique used: | Dual luciferase reporter assay |
Transfection method: | Lipofectamine 2000 |
siRNA expression method: | Invitrogen |
Post-transfection duration: | 24 hours |
OMID ID: | 143100 |
KEGG disease ID: | H00059 |
Reference: | 25849618 |